Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. (Q33399884)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. |
scientific article |
Statements
1 reference
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. (English)
1 reference
Elizabeth Fox
1 reference
Shreyaskumar Patel
1 reference
J Kyle Wathen
1 reference
Scott Schuetze
1 reference
Sant Chawla
1 reference
David Harmon
1 reference
Denise Reinke
1 reference
Rashmi Chugh
1 reference
Robert S Benjamin
1 reference
Lee J Helman
1 reference
23 February 2012
1 reference
Identifiers
1 reference